• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

11.14.2014

Geron to Present at the Stifel Healthcare Conference

Read More

11.13.2014

Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat

Read More

11.6.2014

Geron Announces Presentations at American Society of Hematology Annual Meeting

Read More

 

Events

11.19.2014

Geron Presents at the Stifel Healthcare Conference

Listen to Webcast

Download Presentation

11.14.2014

Conference call to discuss the global stragic collaboration with Janssen

Listen to Webcast

8.11.2014

Geron Q2 2014 Conference Call

Listen to Webcast